Literature DB >> 11259117

Selective cell-cycle arrest and induction of apoptosis in proliferating neural cells by ganglioside GM3.

Y Nakatsuji1, R H Miller.   

Abstract

Control of cell proliferation and cell survival is critical during development of the vertebrate central nervous system (CNS). Much of the cell death seen during early stages of CNS development occurs through apoptosis; however, the factors that induce this early apoptosis are not clearly understood. Gangliosides, sialylated glycosphingolipids, are expressed in the CNS and have been proposed to regulate cell growth and differentiation. Here we show that the simple ganglioside GM3 selectively inhibits the proliferation of and induces apoptosis of actively dividing astrocyte precursors and other neural progenitors. The inhibition of astrocyte precursor proliferation by GM3 appears to be mediated in part by the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1). During neonatal development there is extensive cell proliferation and little apoptosis in the ventricular and subventricular zones of the CNS. This proliferation was dramatically inhibited and the degree of apoptosis dramatically increased following intraventricular administration of GM3. These data suggest that GM3, a simple ganglioside, may regulate cell proliferation and death in the CNS and as such may have potential for brain tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259117     DOI: 10.1006/exnr.2000.7602

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.

Authors:  Elodie Masson; Nicolas Wiernsperger; Michel Lagarde; Samer El Bawab
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 2.  Mammalian neural stem-cell renewal: nature versus nurture.

Authors:  Yvan Arsenijevic
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

3.  Ganglioside GM3 inhibits proliferation and invasion of glioma.

Authors:  Yasunori Fujimoto; Shuichi Izumoto; Tsuyoshi Suzuki; Manabu Kinoshita; Naoki Kagawa; Kouichi Wada; Naoya Hashimoto; Motohiko Maruno; Yuji Nakatsuji; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

4.  GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.

Authors:  Eun S Chung; Eugene Bok; Sunghyang Sohn; Young D Lee; Hyung H Baik; Byung K Jin
Journal:  BMC Neurosci       Date:  2010-06-12       Impact factor: 3.288

5.  Cytotoxic effects of G(M1) ganglioside and amyloid β-peptide on mouse embryonic neural stem cells.

Authors:  Makoto Yanagisawa; Toshio Ariga; Robert K Yu
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

6.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

7.  Gangliosides induce autophagic cell death in astrocytes.

Authors:  Jaegyu Hwang; Shinrye Lee; Jung Tae Lee; Taeg Kyu Kwon; Deok Ryong Kim; Ho Kim; Hae-Chul Park; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

8.  Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke.

Authors:  Sarah Caughlin; Jeffrey D Hepburn; Dae Hee Park; Kristina Jurcic; Ken K-C Yeung; David F Cechetto; Shawn N Whitehead
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 9.  The role of gangliosides in neurodevelopment.

Authors:  Kate Palmano; Angela Rowan; Rozey Guillermo; Jian Guan; Paul McJarrow
Journal:  Nutrients       Date:  2015-05-22       Impact factor: 5.717

10.  Efficient synthesis of chloro-derivatives of sialosyllactosylceramide, and their enhanced inhibitory effect on epidermal growth factor receptor activation.

Authors:  Nagako Kawashima; Huanhuan Qu; Marlin Lobaton; Zhenyuan Zhu; Matthieu Sollogoub; Webster K Cavenee; Kazuko Handa; Sen-Itiroh Hakomori; Yongmin Zhang
Journal:  Oncol Lett       Date:  2014-02-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.